The vaccine administration market is expected to witness a strong one in the coming years. The current trend speaks of digital transformation. In other words, it is about the provision of digital solutions that are presented everywhere. What is important is that key stakeholders cannot afford to keep digital technology in a silo. Unification is the need of the hour to make anytime, anywhere access possible. The company is scheduled to move with the same mindset in the forecast period.
The increasing prevalence of life-threatening diseases around the world increases the demand for the development of new vaccines. Vaccine administration is the process of immunization by placing the vaccine at the port of entry so that it comes into contact with the body. There are several preferred routes for administration of the vaccine in the body, such as intramuscular, subcutaneous, intravenous, and oral administration.
The intramuscular route is the preferred route of vaccine administration due to fewer local adverse events. Currently, the COVID-19 pandemic affects more than 78.9 million people worldwide. More than 1.7 million people have died due to the COVID-19 pandemic to date.
Manufacturers around the world are now focusing on developing vaccines to boost immunity in order to control the adverse impact and death rate due to coronavirus disease. Key market players are also actively pursuing regulatory approval to sell and distribute their COVID-19 vaccine. For example, in December 2020, the US FDA issued emergency use authorization for the distribution of the Pfizer-BioNTech COVID-19 vaccine in the US. The administration of the vaccine is very important for increase the immunity of the pediatric and adult population.
Get a sample copy of this report @ https://www.persistencemarketresearch.com/samples/32468
Vaccine administration prevents countless cases of disease and disability and saves millions of lives around the world. The event of vaccine administration stimulates the body’s immune system by mimicking infectious viruses and bacteria that cause disease. Proper and safe vaccine administration practice is very important to the effectiveness of the vaccine in the body.
Key manufacturers involved in vaccine development are also focusing on maintaining the form of vaccines, such as solid and liquid, for proper vaccine delivery and effect in the body. However, the rising prevalence of life-threatening infectious diseases and government support for vaccine development are expected to create a lucrative growth opportunity for the vaccine delivery market.
Increasing cases of viral and bacterial diseases and rising mortality rate are the main factors expected to drive the growth of the vaccine administration market. Increasing vaccine development activities across the globe are also anticipated to drive the growth of the vaccine administration market during the forecast periods.
The growing preference for intramuscular vaccine delivery was also anticipated to drive the growth of the vaccine delivery market. However, the strict regulatory scenario and secondary effects on the route of administration of vaccines are also expected to limit the growth of the vaccine administration market to some extent.
Table of Contents Request @ https://www.persistencemarketresearch.com/toc/32468
Vaccine Administration Market: Segmentation
Based on the route of administration, the vaccine administration market can be segmented as:
- intramuscular
- Subcutaneous
- Intravenous
- oral administration
- Others
Based on the disease indication, the vaccine administration market can be segmented as:
- Viral diseases
- bacterial diseases
On the basis of age group, the vaccine administration market can be segmented as:
- Pediatrics
- Adults
The demand for the development of new vaccines is increasing in recent years due to the growing pandemic of the coronavirus disease throughout the world. The preference for vaccine delivery to manage the growing burden of COVID-19 is expected to drive the growth of the vaccine delivery market over the years.
Key market players involved in vaccine development are also continually focusing to develop vaccines with lesser side effects in the route of administration of the vaccine as well as in the body for better vaccination result.
Governments of developing and emerging countries taking various initiatives to develop vaccines against infectious diseases are expected to drive the growth of vaccine administration market during the forecast periods. However, the long periods of clinical trials and the strict regulation for the approval of vaccines were anticipated to hamper the growth of the vaccine administration market.
Access the full report @ https://www.persistencemarketresearch.com/checkout/32468
Geographically, the US is anticipated to contribute the largest market share in the vaccine delivery market due to its growing healthcare spending and increased funding for vaccine research and development, followed by Europe. The vaccine administration market is expected to grow fastest in Asia Pacific due to the increasing prevalence of viral and bacterial diseases and the growing economy.
However, in South Asian countries such as India and China, the opportunities for market players to develop and sell vaccines are expected to be greater due to the large population and increased government initiatives to develop vaccines during the forecast periods .
Vaccine Administration Market – Key Market Players
- Pfizer
- AstraZeneca plc. Sanofi Aventis
- Merck & Co Inc.
- GlaxoSmithKline plc.
- Emerging BioSolutions Inc.
- Johnson and Johnson
- CSL limited
- Whey Institute of India Pvt. Limited.
- Bharat Biotech
- VBI Vaccines Inc.
- Sinovac Biotech Ltd.
- Others
About us: persistence market research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
US Phone – +1-646-568-7751
US-Canada Toll Free: +1 800-961 -0353
Sales – sales@persistencemarketresearch.com
